Loading candles…
Innova Captab Ltd, incorporated in January 2005, is an integrated pharmaceutical company based in India. It operates across the entire pharmaceutical value chain, including research and development, manufacturing, and marketing. The company’s business segments include Contract Development and Manufacturing Organization (CDMO) services, domestic branded generics, and international branded generics. Innova Captab serves over 200 CDMO customers as of fiscal year 2025 and maintains a broad distribution network throughout India. It focuses solely on the pharmaceutical industry and does not have any listed subsidiaries or ventures.
| Unaudited Results - Q3-FY15 |
| Intimation of Board Meeting under Regulations 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (i) for consideration of Una… |
| 23 Jan 2026 |
| Results - Q2 & FY25 | To consider and approve the financial results for the quarter and half year ended September 30, 2025 and other business matters | 7 Nov 2025 |
| Unaudited Results - Q1-FY25 | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board… | 7 Aug 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the audited financial results for the quarter and year ended March 31, 2025 and other business matters | 19 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.